Home Top Movers BioLineRx Ltd. (BLRX) stock Popping High in Pre-Market: Why is it so?

BioLineRx Ltd. (BLRX) stock Popping High in Pre-Market: Why is it so?

BioLineRx Ltd. (BLRX) announced positive topline results of its GENESIS Phase 3 trial after which the BLRX stock price saw a surge of 65.52% to reach $5.28 a share as of this writing. BLRX stock went up by 1.59% at the previous closing. Let’s deep dive to explore more of it.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

GENESIS Phase 3 Trial:

GENESIS Phase 3 Trial study is the evaluation of BioLineRx’s lead candidate Motixafortide in combination with granulocyte colony-stimulating factor(G-CSF). This combination is for the hematopoietic stem-cell mobilization for autologous bone marrow transplantation in multiple patients suffering from myeloma.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

122 patients were enrolled in this study and statistical analysis favored the Motixafortide combination with G-CSF in all primary and secondary endpoints. The overall study was impressive, and the combination was safe and well-tolerated. Results show that 90% of patients after undergoing one apheresis session proceeded to transplantation for the arm treatment.

According to the lead investigator of the study John DiPersio, MD, Washington University School of Medicine, the positive GENESIS study would reduce the hospital resources and alleviate the burden of the patients.

CEO Remarks:

The CEO of BioLineRx stock, Philip Serlinsaid that the positive results from the GENESIS phase 3 trial exceeded their expectations and transformational for BLRX stock. Furthermore, BioLineRx’s goal to become standard of care for autologous bone-marrow transplantation would get much support from these positive results.

Financial View of BLRX stock:

  • For the fiscal year ended December 31, 2020, research and development expenses of BLRX stock reduced by 22.5% from the previous year to drop at $18.2 million.
  • Sales and marketing expenses of $0.8 million represented no change in 2020 from 2019.
  • General and administrative expenses increased from $3.8 million in 2019 to $3.9 million in 2020 due to an increase in D&O insurance as well as share-based compensation.
  • Operating loss for BLRX stock totaled $22.9 million for the year 2020 and the net loss reached $30 million as compared to $25.5 million in the previous year.

As of December 31, 2020, BioLineRx had cash, cash equivalents, and short-term bank deposits of $22.6 million.BLRX stock raised $34.5 million and $9.8 million from gross proceeds in an underwritten public offering and exercising of outstanding warrants, respectively.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion:

BLRX stock has captivated the attention of investors after the announcement of positive top-line result GENESIS phase 3 trial. Management is focused to get regulatory approval for Motixafortide as soon as possible. Hence individuals need to keep an eye on this stock.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Amarin Corporation plc (NASDAQ: AMRN) stock plunged in the premarket trading session; here’s why

In the premarket trading session, Amarin Corporation plc (AMRN) stock had plunged by -4.56% to $4.4. AMRN stock closed previous session at $4.61 gaining...

Why Second Sight Medical Products, Inc. (EYES) stock is Popping High today?

Second Sight Medical Products, Inc. (EYES) stock announced two-year results of its Orion Study after which the EYES stock price happened to be green...

Luokung Technology Corp. (LKCO) Stock Undergoes Volatility as Appeal Over CCMC Designation is Underway

Luokung Technology Corp. (LKCO) stock prices were down by 6.40% as of the market closing on May 11th, 2021, bringing the price per share...

Vista Gold Corp. (VGZ) Stock Inches Higher After Promising Q1 2021 Financial Reports

Vista Gold Corp. (VGZ) stock prices were up by an incremental 1.82% as of the market closing on May 11th, 2021, bringing the price...

Array Technologies, Inc. (ARRY) Stock Prices Stay Stable Despite Troubling Q1 2021 Financial Reports

Array Technologies, Inc. (ARRY) stock prices were up by a marginal 0.28% as of the market closing on May 11th, 2021, bringing the price...

Lucira Health Inc. (NASDAQ:LHDX) stock rallied today in the current trading session; here’s why

In the current trading session at last check, Lucira Health Inc. (LHDX) shares had surged by 15.32% to the price of $5.87. LHDX's stock...

PaySign, Inc. (PAYS) Stock Down Following Disclosure of Troubling Q1 2021 Financial Reports

PaySign, Inc. (PAYS) stock prices were down 15.0568% early in the trading day on May 12th, 2021, bringing the price per share down to...

Comstock Mining Inc. (NASDAQ:LODE) stock plunged in the current trading session; here’s why

In the current trading session at the last check, Comstock Mining Inc. (LODE) stock had plunged -3.25% to trade at $3.21. LODE stock previously...

Related News

Why Summit Wireless Technologies, Inc. (WISA) stock is Going high today?

Summit Wireless Technologies, Inc. (WISA) stock, a wireless sound technology company, provided an update for its first quarter ended March 31, 2021, today on...

Contextlogic Inc. (NASDAQ: WISH) stock rises during pre-market session. Let’s figure out why?

Contextlogic Inc. (NASDAQ: WISH) stock plunged by 0.84% at last close whereas the WISH stock price gains by 4.84% during pre-market session. WISH, which...

Biomerica Inc. (NASDAQ: BMRA) stock gains during pre-market. What’s driving it high?

Biomerica Inc. (NASDAQ: BMRA) stock declined by 17.23% at last close but later in pre-market session the BMRA stock soars by 13.78%. Biomerica is...

AgeX Therapeutics Inc. (NYSE:AGE) stock surged in the premarket trading session; here’s why

In the premarket trading session, at last check AGE stock surged by 7.2% to $1.34. AGE stock closed previous session at $1.25 losing -3.85%....

CuriosityStream Inc. (NASDAQ: CURI) stock fell during after-hour. Why is it so?

CuriosityStream Inc. (NASDAQ: CURI) stock declined by 3.37% at last close while the CURI stock continues to fall by 11.99% in the after-hour trading....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.